发明名称 |
ALKYL [(S)-1-((S)-2-{5-[4-(4-{2-[(S)-1-((S)-2-METHOXYCARBONYLAMINO-3-METHYL-BUTYRYL)-PYRROLIDINE-2-YL]-3H-IMIDAZOLE-4-YL}-BUTA-1,3-DIENYL)-PHENYL]-1H-IMIDAZOLE-2-YL}-PYRROLIDINE-1-CARBONYL)-2-METHYL-PROPYL]-CARBAMATE NAPHTHALENE-1,5-DISULFONATE FOR THE TREATMENT OF VIRAL DISEASES |
摘要 |
The present invention relates to NS5A inhibitors, to a novel pharmaceutical composition, to an antiviral medicinal agent, and to a method for the prevention and treatment of viral diseases, particularly those caused by the hepatitis C (HCV) and hepatitis GBV-C viruses. Proposed are alkyl [(S)-1-((S)-2-{5-[4-(4-{2-[(S)-1-((S)-2-methoxycarbonylamino-3-methyl-butyryl)-pyrrolidine-2-yl]-3H-imidazole-4-yl}-buta-1,3-dienyl)-phenyl]-1H-imidazole-2-yl}-pyrrolidine-1-carbonyl)-2-methyl-propyl]-carbamate naphthalene-1,5-disulfonate of general formula 1, in crystalline or polycrystalline form, where: R is C1-C3 alkyl. |
申请公布号 |
WO2014123456(A3) |
申请公布日期 |
2014.12.18 |
申请号 |
WO2014RU00079 |
申请日期 |
2014.02.04 |
申请人 |
IVACHTCHENKO, ALEXANDRE VASILIEVICH;IVASHCHENKO, ANDREY ALEXANDROVICH;SAVCHUK, NIKOLAY FILIPPOVICH |
发明人 |
IVACHTCHENKO, ALEXANDRE VASILIEVICH |
分类号 |
C07D403/04;A61K31/4178;A61P31/12;C07C303/32 |
主分类号 |
C07D403/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|